Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2015

Stachler MD, Taylor-Weiner A, Peng S, McKenna A, Agoston AT, Odze RD, et al. Paired exome analysis of Barrett's esophagus and adenocarcinoma. Nat Genet. 2015;47(9):1047-55.

Pagan JK, Marzio A, Jones MJ, Saraf A, Jallepalli PV, Florens L, et al. Degradation of Cep68 and PCNT cleavage mediate Cep215 removal from the PCM to allow centriole separation, disengagement and licensing. Nat Cell Biol. 2015;17(1):31-43.

Robinson D, Van Allen EM, Wu Y-, Schultz N, Lonigro RJ, Mosquera J-, et al. Integrative clinical genomics of advanced prostate cancer. Cell. 2015;161(5):1215-1228.

Liu L, Cohen C, Siddiqui MT. Expression of ProEx C in primary and metastatic urothelial carcinoma. Diagn Cytopathol. 2015;43(3):181-7.

Srivatana V, Muthukumar T, Lee JB, Seshan SV, Hartono C. Quiz Page August 2015: Leukemoid Reaction and Acute Kidney Injury Following Kidney Transplantation. Am J Kidney Dis. 2015;66(2):xx-xxiii.

Arvey A, Ojesina AI, Pedamallu CS, Ballon G, Jung J, Duke F, et al. The tumor virus landscape of AIDS-related lymphomas. Blood. 2015;125(20):e14-22.

Margetis K, Rajappa P, Cope W, Pisapia D, Souweidane MM. Endoscopic diagnosis of an MRI-occult, low-grade glioma with ependymal dissemination. J Neurosurg Pediatr. 2015;16(4):377-82.

Pandit-Taskar N, O'Donoghue JA, Durack JC, Lyashchenko SK, Cheal SM, Beylergil V, et al. A Phase I/II Study for Analytic Validation of 89Zr-J591 ImmunoPET as a Molecular Imaging Agent for Metastatic Prostate Cancer. Clin Cancer Res. 2015;21(23):5277-85.

Mathieu R, Klatte T, Margulis V, Karam JA, Rouprêt M, Seitz C, et al. Survivin is not an independent prognostic factor for patients with upper tract urothelial carcinoma: a multi-institutional study. Urol Oncol. 2015;33(11):495.e15-22.

Piva R, Deaglio S, Famà R, Buonincontri R, Scarfò I, Bruscaggin A, et al. The Krüppel-like factor 2 transcription factor gene is recurrently mutated in splenic marginal zone lymphoma. Leukemia. 2015;29(2):503-7.